Puissance Capital Management LP

10% owner at Bellerophon Therapeutics, Inc.; 10% owner at Tracon Pharmaceuticals, Inc.

Sold, on record
$6.5M
Dollars the filings state
Form 4 sales
3
Latest Jun 7, 2023
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Tracon Pharmaceuticals, Inc.Unusual
    Dec 9, 2019 2019

    Sold 384,130 shares at $2.93 ($1.1M)

    Puissance Capital Management LP, 10% owner

    Sold 83.5% of holdings ($1.4M position)76,048 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Bellerophon Therapeutics, Inc.Unusual
    May 18, 2023 +1256 days

    Sold 560,000 shares at $9.46 ($5.3M)

    Puissance Capital Management LP, 10% owner

    No 10b5-1 planSold 31.6% of holdings ($16.8M position)1.2M shares leftFirst sale on recordFiling

  3. 3 Form 4 sale Bellerophon Therapeutics, Inc.No plan
    Jun 7, 2023 +20 days

    Sold 134,421 shares at $0.83 ($112k)

    Puissance Capital Management LP, 10% owner

    No 10b5-1 planSold 11.1% of holdings ($1M position)1.1M shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Puissance Capital Management LP
Source
Jun 7, 2023Jun 7, 2023Bellerophon Therapeutics, Inc.10% ownerForm 4 sale134,421$112k11.1%No planSEC
May 18, 2023May 19, 2023Bellerophon Therapeutics, Inc.10% ownerForm 4 sale560,000$5.3M31.6%UnusualSEC
Dec 9, 2019Dec 11, 2019Tracon Pharmaceuticals, Inc.10% ownerForm 4 sale384,130$1.1M83.5%UnusualSEC